Evolving Public Attention to Steatotic Liver Disease: A 20-Year Analysis (2004-2024): Surging Steatotic Liver Disease Focus [0.03%]
脂肪性肝病公众关注度的二十年演变（2004-2024）：脂肪性肝病研究热度激增
Pojsakorn Danpanichkul,Charat Thongprayoon,Kanokphong Suparan et al.
Pojsakorn Danpanichkul et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over one third of the global population and is closely linked to gastrointestinal, oncological, and cardiovascular diseases. As the most...
Future Perspectives of Liver Research in the Asia-Pacific Region: Focus on Hepatitis B and C [0.03%]
亚太地区肝病研究展望：以乙型和丙型肝炎为重点
Beom Kyung Kim
Beom Kyung Kim
The Asia-Pacific region faces serious liver health challenges, primarily because of the comparatively high prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, as well as the increasing disease burden of metabolic-a...
Performance of the AASLD, EASL, and APASL Clinical Practice Guidelines in"grey zone"stages of Chinese patients with chronic hepatitis B [0.03%]
AASLD、EASL和APASL慢性乙型肝炎临床指南在中国患者“灰色地带”阶段的适用性分析
Hang-Yu Ma,Xue-Yan Yang,Yu-Xin Tian et al.
Hang-Yu Ma et al.
Background/objective: Chronic hepatitis B (CHB) patients who do not meet any immunostaging criteria are categorized as the "grey zone" (GZ). However, there are discrepancies in the definition of the GZ in different areas....
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group [0.03%]
泊沙康唑改善原发性胆汁性胆管炎患者的肝生化指标和GLOBE评分：日本红十字会肝病研究组的全国多中心研究
Keiji Tsuji,Nobuharu Tamaki,Masayuki Kurosaki et al.
Keiji Tsuji et al.
Aim: We aimed to evaluate the effect of pemafibrate, a selective peroxisome proliferator-activated receptor-α modulator, on patients with primary biliary cholangitis (PBC) complicated by dyslipidemia. ...
Privacy and fidelity: The promise of synthetic data in hepatology research [0.03%]
隐私与忠诚：合成数据在肝病学研究中的前景
Oren K Fix,Michael Kane,Christina S Gainey et al.
Oren K Fix et al.
A scientometric analysis and visualization of research on fatty liver diseases in Iran from 2003 to 2023 [0.03%]
2003-2023年伊朗脂肪肝疾病研究的科学计量分析与可视化
Ehsaneh Taheri,Hamideh Ehtesham,Reza Safdari et al.
Ehsaneh Taheri et al.
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and is now a major global health threat. Due to the mechanistic links between these conditions, along with ...
Experimental Liver Surgery for Liver Research: Update, Choice and Translation [0.03%]
实验性肝脏外科手术在肝病研究中的应用：更新、选择和转化
Ji-Hua Shi,Pål-Dag Line,Shui-Jun Zhang et al.
Ji-Hua Shi et al.
Experimental animal models of liver surgery are crucial for understanding human liver physiology and pathogenesis and identifying novel therapeutic modalities for liver disease. Herein, we update the brief summary of the most widely used ex...
AI-driven synthetic data generation for accelerating hepatology research: A study of the United Network for Organ Sharing (UNOS) database [0.03%]
基于人工智能的合成数据生成，加速肝脏研究：对器官共享联合网络（UNOS）数据库的研究
Joseph C Ahn,Yung-Kyun Noh,Mingzhao Hu et al.
Joseph C Ahn et al.
Background and aims: Clinical hepatology research often faces limited data availability, underrepresentation of minority groups, and complex data-sharing regulations. Synthetic data-artificially generated patient records ...
耗时 0.38766 秒，为您在
48206918
条记录里面共找到 777 篇文章 [XML]